Cargando…
Survival rates of patients with metastatic malignant melanoma
Rationale: Malignant melanoma (MM) is the cutaneous neoplasia with the greatest mortality rates and one of the malignancies with the highest potential of dissemination. The prognosis of patients with metastatic MM is grim, with a 5-years survival rate between 5-19%, and is dictated by the location a...
Autores principales: | Sandru, A, Voinea, S, Panaitescu, E, Blidaru, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316142/ https://www.ncbi.nlm.nih.gov/pubmed/25713625 |
Ejemplares similares
-
Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Simultaneous determination of two serum tumor markers in assessing malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Impact of gender and primary tumor location on outcome of patients with cutaneous melanoma
por: Voinea, S, et al.
Publicado: (2016) -
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014)